Literature DB >> 2105706

Fluoxetine and side effects.

R J Baldessarini, E Marsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105706     DOI: 10.1001/archpsyc.1990.01810140091015

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  14 in total

1.  Extrapyramidal symptoms in a patient treated with fluvoxamine.

Authors:  V Wils
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

2.  Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.

Authors:  J Tiihonen; M Kuoppamäki; K Någren; J Bergman; E Eronen; E Syvälahti; J Hietala
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

3.  Investigation of whole blood and urine monoamines in autism.

Authors:  Josiane Hérault; Joëlle Martineau; Anne Perrot-Beaugerie; Jacqueline Jouve; Hervé Tournade; Catherine Barthelemy; Gilbert Lelord; Jean-Pierre Muh
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-10       Impact factor: 4.785

4.  Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.

Authors:  R Ramasubbu
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 6.  Drug therapy for geriatric depression.

Authors:  R Bressler; M D Katz
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

7.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

8.  Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.

Authors:  S Prisco; E Esposito
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

Review 9.  Management of the negative symptoms of schizophrenia: new treatment options.

Authors:  Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Fluoxetine: a review of receptor and functional effects and their clinical implications.

Authors:  C M Beasley; D N Masica; J H Potvin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.